HoldingsChannel.com
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
|---|---|---|---|
 Pharvaris N.V. |
4,038,842 | +295,392 | $113,290 |
| PHVS | 4,038,842 | +295,392 | $113,290 |
| Kura Oncology Inc. |
1,849,947 | UNCH | $26,602 |
| KURA | 1,849,947 | UNCH | $26,602 |
| Kinnate Biopharma Inc. |
9,671,643 | UNCH | $22,922 |
| KNTE | 9,671,643 | UNCH | $22,922 |
| Syndax Pharmaceuticals Inc. |
875,000 | UNCH | $18,909 |
| SNDX | 875,000 | UNCH | $18,909 |
| Lyell Immunopharma Inc. |
8,325,000 | -459,813 | $16,150 |
| LYEL | 8,325,000 | -459,813 | $16,150 |
 Aclaris Therapeutics Inc. |
$0 (exited) | ||
| ACRS | 0 | -2,808,034 | $0 |
| Cymabay Therapeutics Inc. |
0 | -1,787,094 | $0 (exited) |
| CBAY | 0 | -1,787,094 | $0 |
See Summary: Foresite Capital Management IV LLC Top Holdings
See Details: Top 10 Stocks Held By Foresite Capital Management IV LLC
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| CBAY | -1,787,094 | -$26,646 |
| ACRS | -2,808,034 | -$19,235 |
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| PHVS | +295,392 | +$35,164 |
| KURA | UNCH | +$9,730 |
| KNTE | UNCH | +$9,382 |
| SNDX | UNCH | +$6,204 |
| LYEL | -459,813 | +$3,236 |
|
Size ($ in 1000's)
At 12/31/2023: $197,873 At 09/30/2023: $180,038 Foresite Capital Management IV LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Foresite Capital Management IV LLC 13F filings. Link to 13F filings: SEC filings |
